TWD 23.8
(-4.42%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 13.32 Million TWD | 17.22% |
2022 | 11.36 Million TWD | -52.64% |
2021 | 24 Million TWD | -36.24% |
2020 | 37.64 Million TWD | 252.34% |
2019 | 10.68 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 14.38 Million TWD | 7.95% |
2024 Q2 | 14.08 Million TWD | -2.04% |
2023 Q3 | 6.12 Million TWD | -16.38% |
2023 FY | 13.32 Million TWD | 17.22% |
2023 Q1 | 9.45 Million TWD | 0.0% |
2023 Q2 | 7.31 Million TWD | -22.6% |
2023 Q4 | 13.32 Million TWD | 117.7% |
2022 Q4 | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.692% |
Level Biotechnology Inc. | 13.5 Million TWD | 1.326% |
TaiMed Biologics Inc. | 750.85 Million TWD | 98.226% |
GlycoNex Incorporation | 900 Thousand TWD | -1380.333% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 94.817% |
OBI Pharma, Inc. | 501.05 Million TWD | 97.341% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 95.838% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 95.302% |
Visgeneer Inc. | 158.6 Million TWD | 91.6% |
Neith Corporation | 3.54 Million TWD | -276.25% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -5.654% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.325% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -1037.746% |
Enimmune corporation | 45.73 Million TWD | 70.869% |
TaiRx, Inc. | 12.28 Million TWD | -8.441% |
CHO Pharma, Inc. | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 77.111% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 96.596% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -125.89% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -23.384% |
Lukas Biomedical Inc. | 82.55 Million TWD | 83.862% |
RBC Bioscience Corporation | 487.36 Million TWD | 97.266% |
NaviFUS Corp. | 32.69 Million TWD | 59.248% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -270.908% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2376.394% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 7.318% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | 88.256% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1431.379% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -1.764% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -145.314% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 50.876% |
Lin BioScience, Inc. | 42.87 Million TWD | 68.924% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -863.341% |
AP Biosciences Inc | 82.07 Million TWD | 83.768% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 92.347% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.046% |
EirGenix Inc. | 465.16 Million TWD | 97.136% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 90.772% |
Mycenax Biotech Inc. | 726.27 Million TWD | 98.166% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -530.227% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -205.994% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 86.249% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 93.19 Million TWD | 85.705% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 96.805% |
Sinew Pharma Inc. | 6.46 Million TWD | -106.111% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 93.207% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.542% |
3D Global Biotech Inc. | 10.37 Million TWD | -28.365% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.072% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.652% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -67.143% |
TCI GENE Inc. | 6.79 Million TWD | -96.071% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -60.171% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -38.767% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 95.04% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -24.724% |
PharmaEngine, Inc. | 14.8 Million TWD | 10.034% |
Savior Lifetec Corporation | 270.37 Million TWD | 95.072% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 82.162% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 60.86% |
Acepodia, Inc. | 273.81 Million TWD | 95.134% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 34.876% |